HB Wealth Management LLC Sells 9,179 Shares of Zoetis Inc. $ZTS

Key Points

• HB Wealth Management LLC cut its Zoetis stake by 50.6%, selling 9,179 shares and retaining 8,955 shares worth about $1.13 million as of the most recent 13F filing.
• Analysts are mixed on Zoetis with a consensus rating of Hold and a $152.25 target; the breakdown is 7 Buys, 7 Holds and 1 Sell, and some firms (e.g., Piper Sandler) have trimmed price targets recently.
• Zoetis beat Q results (EPS $1.48 vs. $1.40 expected) with revenue up 3% to $2.39 billion, set FY2026 guidance of 7.00–7.10 EPS, and announced a quarterly dividend of $0.53 (annualized yield ~1.8%).

HB Wealth Management LLC lowered its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 50.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,955 shares of the company's stock after selling 9,179 shares during the period. HB Wealth Management LLC's holdings in Zoetis were worth $1,127,000 as of its most recent filing with the SEC.

Other large investors have also bought and sold shares of the company. Halbert Hargrove Global Advisors LLC boosted its stake in Zoetis by 496.6% in the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company's stock valued at $25,000 after buying an additional 144 shares in the last quarter. Global Wealth Strategies & Associates acquired a new stake in Zoetis in the fourth quarter valued at about $25,000. KERR FINANCIAL PLANNING Corp acquired a new stake in Zoetis in the third quarter valued at about $31,000. Lodestone Wealth Management LLC acquired a new stake in Zoetis in the fourth quarter valued at about $30,000. Finally, Holos Integrated Wealth LLC acquired a new stake in Zoetis in the fourth quarter valued at about $32,000. 92.80% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Piper Sandler reaffirmed a "neutral" rating and issued a $135.00 price objective (down from $190.00) on shares of Zoetis in a research note on Thursday, January 22nd. Wall Street Zen raised Zoetis from a "hold" rating to a "buy" rating in a research note on Saturday, February 21st. William Blair reaffirmed an "outperform" rating on shares of Zoetis in a research note on Monday, March 2nd. Weiss Ratings lowered Zoetis from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Friday, March 27th. Finally, BTIG Research reaffirmed a "buy" rating and issued a $160.00 price objective on shares of Zoetis in a research note on Thursday, February 26th. Seven equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $152.25.

Zoetis Stock Performance

Shares of ZTS stock opened at $116.92 on Monday. The business's 50-day moving average price is $120.83 and its 200-day moving average price is $125.28. Zoetis Inc. has a 12 month low of $113.29 and a 12 month high of $172.23. The firm has a market capitalization of $49.18 billion, a price-to-earnings ratio of 19.42, a PEG ratio of 1.78 and a beta of 0.98. The company has a current ratio of 3.03, a quick ratio of 1.94 and a debt-to-equity ratio of 2.71.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Thursday, February 12th. The company reported $1.48 EPS for the quarter, beating analysts' consensus estimates of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The firm had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.36 billion. During the same period last year, the firm posted $1.40 earnings per share. The business's revenue for the quarter was up 3.0% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Equities research analysts forecast that Zoetis Inc. will post 7.02 EPS for the current year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis's dividend payout ratio (DPR) is presently 35.22%.

About Zoetis

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.